Neurofibromatosis 2 (NF2) patients with constitutional splice site NF2 mutations have greater variability in disease severity than NF2 patients with other types of mutations; the cause of this variability is unknown. We evaluated genotype-phenotype correlations, with particular focus on the location of splice site mutations, using mutation and clinical information on 831 patients from 528 NF2 families with identified constitutional NF2 mutations. The clinical characteristics examined were age at onset of symptoms of NF2 and number of intracranial meningiomas, which are the primary indices of the severity of NF2. Two regression models were used to analyse genotype-phenotype correlations. People with splice site mutations in exons 1–5 had more severe disease than those with splice site mutations in exons 11–15. This result is compatible with studies showing that exons 2 and 3 are required for self-association of the amino terminal of the NF2 protein in vitro, and that deletions of exons 2 and 3 in transgenic and knockout mouse models of NF2 cause a high prevalence of Schwann cell derived tumours.

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 / M. E. Baser; L. Kuramoto; R. Woods; H. Joe; J. M. Friedman; A. J. Wallace; R. T. Ramsden; S. Olschwang; E. Bijlsma; M. Kalamarides; L. Papi; R. Kato; J. Carroll; C. Lázaro; F. Joncourt; D. M. Parry; G. A. Rouleau; D. G R. - In: JOURNAL OF MEDICAL GENETICS. - ISSN 0022-2593. - STAMPA. - 42:(2005), pp. 540-546. [10.1136/jmg.2004.029504]

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

PAPI, LAURA;
2005

Abstract

Neurofibromatosis 2 (NF2) patients with constitutional splice site NF2 mutations have greater variability in disease severity than NF2 patients with other types of mutations; the cause of this variability is unknown. We evaluated genotype-phenotype correlations, with particular focus on the location of splice site mutations, using mutation and clinical information on 831 patients from 528 NF2 families with identified constitutional NF2 mutations. The clinical characteristics examined were age at onset of symptoms of NF2 and number of intracranial meningiomas, which are the primary indices of the severity of NF2. Two regression models were used to analyse genotype-phenotype correlations. People with splice site mutations in exons 1–5 had more severe disease than those with splice site mutations in exons 11–15. This result is compatible with studies showing that exons 2 and 3 are required for self-association of the amino terminal of the NF2 protein in vitro, and that deletions of exons 2 and 3 in transgenic and knockout mouse models of NF2 cause a high prevalence of Schwann cell derived tumours.
2005
42
540
546
M. E. Baser; L. Kuramoto; R. Woods; H. Joe; J. M. Friedman; A. J. Wallace; R. T. Ramsden; S. Olschwang; E. Bijlsma; M. Kalamarides; L. Papi; R. Kato; J. Carroll; C. Lázaro; F. Joncourt; D. M. Parry; G. A. Rouleau; D. G R
File in questo prodotto:
File Dimensione Formato  
The location of constitutional neurofibromatosis 2 (NF2).pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Tutti i diritti riservati
Dimensione 99.47 kB
Formato Adobe PDF
99.47 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/331281
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 72
social impact